The apraxia of speech rating scale: A tool for diagnosis and description of apraxia of speech

•The ASRS quantifies the frequency/severity of the characteristics associated with AOS.•ASRS correlates with clinical diagnosis and severity of AOS.•Overall intra-judge and inter-judge reliability is acceptable.•Sensitivity and specificity of the ASRS are acceptable. The purpose of this report is to...

Full description

Saved in:
Bibliographic Details
Published inJournal of communication disorders Vol. 51; no. NA; pp. 43 - 50
Main Authors Strand, Edythe A., Duffy, Joseph R., Clark, Heather M., Josephs, Keith
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.09.2014
Subjects
Online AccessGet full text

Cover

Loading…
Abstract •The ASRS quantifies the frequency/severity of the characteristics associated with AOS.•ASRS correlates with clinical diagnosis and severity of AOS.•Overall intra-judge and inter-judge reliability is acceptable.•Sensitivity and specificity of the ASRS are acceptable. The purpose of this report is to describe an initial version of the Apraxia of Speech Rating Scale (ASRS), a scale designed to quantify the presence or absence, relative frequency, and severity of characteristics frequently associated with apraxia of speech (AOS). In this paper we report intra-judge and inter-judge reliability, as well as indices of validity, for the ASRS which was completed for 133 adult participants with a neurodegenerative speech or language disorder, 56 of whom had AOS. The overall inter-judge ICC among three clinicians was 0.94 for the total ASRS score and 0.91 for the number of AOS characteristics identified as present. Intra-judge ICC measures were high, ranging from 0.91 to 0.98. Validity was demonstrated on the basis of strong correlations with independent clinical diagnosis, as well as strong correlations of ASRS scores with independent clinical judgments of AOS severity. Results suggest that the ASRS is a potentially useful tool for documenting the presence and severity of characteristics of AOS. At this point in its development it has good potential for broader clinical use and for better subject description in AOS research. Learning Outcomes: The Apraxia of Speech Rating Scale: A new tool for diagnosis and description of apraxia of speech1.The reader will be able to explain characteristics of apraxia of speech.2.The reader will be able to demonstrate use of a rating scale to document the presence and severity of speech characteristics.3.The reader will be able to explain the reliability and validity of the ASRS.
AbstractList The purpose of this report is to describe an initial version of the Apraxia of Speech Rating Scale (ASRS), a scale designed to quantify the presence or absence, relative frequency, and severity of characteristics frequently associated with apraxia of speech (AOS). In this paper we report intra-judge and inter-judge reliability, as well as indices of validity, for the ASRS which was completed for 133 adult participants with a neurodegenerative speech or language disorder, 56 of whom had AOS. The overall inter-judge ICC among three clinicians was 0.94 for the total ASRS score and 0.91 for the number of AOS characteristics identified as present. Intra-judge ICC measures were high, ranging from 0.91 to 0.98. Validity was demonstrated on the basis of strong correlations with independent clinical diagnosis, as well as strong correlations of ASRS scores with independent clinical judgments of AOS severity. Results suggest that the ASRS is a potentially useful tool for documenting the presence and severity of characteristics of AOS. At this point in its development it has good potential for broader clinical use and for better subject description in AOS research. The Apraxia of Speech Rating Scale: A new tool for diagnosis and description of apraxia of speech 1. The reader will be able to explain characteristics of apraxia of speech. 2. The reader will be able to demonstrate use of a rating scale to document the presence and severity of speech characteristics. 3. The reader will be able to explain the reliability and validity of the ASRS.
•The ASRS quantifies the frequency/severity of the characteristics associated with AOS.•ASRS correlates with clinical diagnosis and severity of AOS.•Overall intra-judge and inter-judge reliability is acceptable.•Sensitivity and specificity of the ASRS are acceptable. The purpose of this report is to describe an initial version of the Apraxia of Speech Rating Scale (ASRS), a scale designed to quantify the presence or absence, relative frequency, and severity of characteristics frequently associated with apraxia of speech (AOS). In this paper we report intra-judge and inter-judge reliability, as well as indices of validity, for the ASRS which was completed for 133 adult participants with a neurodegenerative speech or language disorder, 56 of whom had AOS. The overall inter-judge ICC among three clinicians was 0.94 for the total ASRS score and 0.91 for the number of AOS characteristics identified as present. Intra-judge ICC measures were high, ranging from 0.91 to 0.98. Validity was demonstrated on the basis of strong correlations with independent clinical diagnosis, as well as strong correlations of ASRS scores with independent clinical judgments of AOS severity. Results suggest that the ASRS is a potentially useful tool for documenting the presence and severity of characteristics of AOS. At this point in its development it has good potential for broader clinical use and for better subject description in AOS research. Learning Outcomes: The Apraxia of Speech Rating Scale: A new tool for diagnosis and description of apraxia of speech1.The reader will be able to explain characteristics of apraxia of speech.2.The reader will be able to demonstrate use of a rating scale to document the presence and severity of speech characteristics.3.The reader will be able to explain the reliability and validity of the ASRS.
The purpose of this report is to describe an initial version of the Apraxia of Speech Rating Scale (ASRS), a scale designed to quantify the presence or absence, relative frequency, and severity of characteristics frequently associated with apraxia of speech (AOS). In this paper we report intra-judge and inter-judge reliability, as well as indices of validity, for the ASRS which was completed for 133 adult participants with a neurodegenerative speech or language disorder, 56 of whom had AOS. The overall inter-judge ICC among three clinicians was 0.94 for the total ASRS score and 0.91 for the number of AOS characteristics identified as present. Intra-judge ICC measures were high, ranging from 0.91 to 0.98. Validity was demonstrated on the basis of strong correlations with independent clinical diagnosis, as well as strong correlations of ASRS scores with independent clinical judgments of AOS severity. Results suggest that the ASRS is a potentially useful tool for documenting the presence and severity of characteristics of AOS. At this point in its development it has good potential for broader clinical use and for better subject description in AOS research.UNLABELLEDThe purpose of this report is to describe an initial version of the Apraxia of Speech Rating Scale (ASRS), a scale designed to quantify the presence or absence, relative frequency, and severity of characteristics frequently associated with apraxia of speech (AOS). In this paper we report intra-judge and inter-judge reliability, as well as indices of validity, for the ASRS which was completed for 133 adult participants with a neurodegenerative speech or language disorder, 56 of whom had AOS. The overall inter-judge ICC among three clinicians was 0.94 for the total ASRS score and 0.91 for the number of AOS characteristics identified as present. Intra-judge ICC measures were high, ranging from 0.91 to 0.98. Validity was demonstrated on the basis of strong correlations with independent clinical diagnosis, as well as strong correlations of ASRS scores with independent clinical judgments of AOS severity. Results suggest that the ASRS is a potentially useful tool for documenting the presence and severity of characteristics of AOS. At this point in its development it has good potential for broader clinical use and for better subject description in AOS research.The Apraxia of Speech Rating Scale: A new tool for diagnosis and description of apraxia of speech 1. The reader will be able to explain characteristics of apraxia of speech. 2. The reader will be able to demonstrate use of a rating scale to document the presence and severity of speech characteristics. 3. The reader will be able to explain the reliability and validity of the ASRS.LEARNING OUTCOMESThe Apraxia of Speech Rating Scale: A new tool for diagnosis and description of apraxia of speech 1. The reader will be able to explain characteristics of apraxia of speech. 2. The reader will be able to demonstrate use of a rating scale to document the presence and severity of speech characteristics. 3. The reader will be able to explain the reliability and validity of the ASRS.
Highlights • The ASRS quantifies the frequency/severity of the characteristics associated with AOS. • ASRS correlates with clinical diagnosis and severity of AOS. • Overall intra-judge and inter-judge reliability is acceptable. • Sensitivity and specificity of the ASRS are acceptable.
Author Strand, Edythe A.
Clark, Heather M.
Duffy, Joseph R.
Josephs, Keith
Author_xml – sequence: 1
  givenname: Edythe A.
  surname: Strand
  fullname: Strand, Edythe A.
  email: strand.edythe@mayo.edu
– sequence: 2
  givenname: Joseph R.
  orcidid: 0000-0001-8206-3432
  surname: Duffy
  fullname: Duffy, Joseph R.
  email: jduffy@mayo.edu
– sequence: 3
  givenname: Heather M.
  surname: Clark
  fullname: Clark, Heather M.
  email: Clark.Heather1@mayo.edu
– sequence: 4
  givenname: Keith
  surname: Josephs
  fullname: Josephs, Keith
  email: Josephs.Keith@mayo.edu
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25092638$$D View this record in MEDLINE/PubMed
BookMark eNqNks1uEzEUhS1URNPCI4C8ZJPUf-MZgyiqKgpIlVhQlsjy2HcSh4k9tScVfXs8SqigCLUrL-45n47vuUfoIMQACL2kZEEJlSfrxdrGjfN5wQgVCyIXhDRP0Iw2NZ_XSokDNCOE0blSTByio5zXpPgkpc_QIauIYpI3M_T9agXYDMn89AbHDucBwK5wMqMPS5yt6eENPsNjjD3uYsLOm2WI2WdsgsMOsk1-GH0Mk_kfznP0tDN9hhf79xh9u_hwdf5pfvnl4-fzs8u5rUU1zgUVvK0ld9RUHWlVVfLXpuIdd5J3llHiRG1aIk3V1CArZxplauoENE3dtA0_Rqc77rBtN-AshDGZXg_Jb0y61dF4_fck-JVexhstWCU4owXweg9I8XoLedQbny30vQkQt1lTqbgkkrP6EVKmVNlzw4r01Z-x7vL8Xn8RVDuBTTHnBN2dhBI91azXel-znmrWROpSc_G9veezfjRTDeV3vn_Q_X7nhlLJjYeks_UQLDifwI7aRf8g4fQewfY--HItP-AW8jpuUyh9a6oz00R_nQ5xukMqCCGVmgDv_g94RIBfmS3waA
CitedBy_id crossref_primary_10_1016_j_bandl_2016_09_009
crossref_primary_10_1002_14651858_CD015067_pub2
crossref_primary_10_3390_brainsci12121705
crossref_primary_10_1044_2022_AJSLP_21_00236
crossref_primary_10_1016_j_cortex_2022_02_012
crossref_primary_10_1044_2022_AJSLP_21_00355
crossref_primary_10_1080_02687038_2020_1787732
crossref_primary_10_1044_2023_AJSLP_22_00302
crossref_primary_10_1044_2023_AJSLP_22_00300
crossref_primary_10_1044_2023_AJSLP_22_00301
crossref_primary_10_1016_j_neuropsychologia_2015_12_010
crossref_primary_10_1038_s41467_021_23687_8
crossref_primary_10_1016_j_cortex_2022_10_010
crossref_primary_10_1093_brain_awad327
crossref_primary_10_1044_2015_AJSLP_14_0174
crossref_primary_10_1016_j_trci_2019_09_005
crossref_primary_10_1016_j_nicl_2018_02_036
crossref_primary_10_1080_02687038_2020_1836319
crossref_primary_10_1044_2018_AJSLP_17_0186
crossref_primary_10_3390_brainsci14060540
crossref_primary_10_1044_2022_JSLHR_22_00438
crossref_primary_10_1044_2020_JSLHR_20_00061
crossref_primary_10_1080_02687038_2017_1385050
crossref_primary_10_1080_02687038_2022_2038367
crossref_primary_10_2496_hbfr_44_156
crossref_primary_10_1080_02687038_2018_1510111
crossref_primary_10_1001_jamaneurol_2018_2287
crossref_primary_10_3390_brainsci12030378
crossref_primary_10_1080_02643294_2023_2186782
crossref_primary_10_1016_j_nrl_2022_09_003
crossref_primary_10_1016_j_brs_2019_07_007
crossref_primary_10_1016_j_nicl_2019_102152
crossref_primary_10_1590_2317_1782_20232022251en
crossref_primary_10_1161_STROKEAHA_115_009211
crossref_primary_10_1515_CJAL_2024_0402
crossref_primary_10_1044_2021_AJSLP_20_00141
crossref_primary_10_1371_journal_pone_0192773
crossref_primary_10_1044_2024_JSLHR_23_00007
crossref_primary_10_1044_2017_AJSLP_16_0103
crossref_primary_10_1111_1460_6984_12494
crossref_primary_10_1016_j_clinph_2023_02_176
crossref_primary_10_1093_brain_awac454
crossref_primary_10_1016_j_bandl_2021_105025
crossref_primary_10_1080_17518423_2021_1916113
crossref_primary_10_1002_brb3_3346
crossref_primary_10_1093_cercor_bhx100
crossref_primary_10_1590_2317_1782_20232022012en
crossref_primary_10_1007_s10072_023_07149_1
crossref_primary_10_1016_j_cortex_2021_03_017
crossref_primary_10_1080_13554794_2016_1172645
crossref_primary_10_3389_fneur_2021_634065
crossref_primary_10_1016_j_conctc_2024_101406
crossref_primary_10_1093_brain_awx363
crossref_primary_10_1044_2016_JSLHR_S_16_0140
crossref_primary_10_1177_15459683211017507
crossref_primary_10_1080_02699206_2024_2345353
crossref_primary_10_1016_j_bandl_2017_01_012
crossref_primary_10_1044_2020_JSLHR_20_00253
crossref_primary_10_1044_2020_AJSLP_19_00135
crossref_primary_10_1212_CPJ_0000000000000919
crossref_primary_10_1016_j_arrct_2024_100339
crossref_primary_10_6000_2292_2598_2023_11_03_1
crossref_primary_10_1016_j_cortex_2015_05_013
crossref_primary_10_1080_02643294_2020_1847059
crossref_primary_10_1002_14651858_CD015067
crossref_primary_10_1017_S0714980817000502
crossref_primary_10_1016_j_cortex_2021_01_012
crossref_primary_10_1044_2023_JSLHR_22_00439
crossref_primary_10_1080_02687038_2017_1378799
crossref_primary_10_1590_2317_1782_20232022251pt
crossref_primary_10_2490_jjrmc_61_942
crossref_primary_10_1080_02687038_2021_1975636
crossref_primary_10_1080_02687038_2018_1508637
crossref_primary_10_1044_2019_JSLHR_L_RSNP_19_0021
crossref_primary_10_1044_2024_AJSLP_23_00424
crossref_primary_10_1044_2024_JSLHR_24_00304
crossref_primary_10_1016_j_bandl_2023_105314
crossref_primary_10_1044_2023_PERSP_23_00043
crossref_primary_10_1002_hbm_26704
crossref_primary_10_1097_TLD_0000000000000204
crossref_primary_10_1044_2022_AJSLP_22_00148
crossref_primary_10_1097_WNN_0000000000000371
crossref_primary_10_3390_brainsci15030271
crossref_primary_10_1044_2022_JSLHR_21_00519
crossref_primary_10_1136_jnnp_2021_328422
crossref_primary_10_1044_2022_AJSLP_22_00140
crossref_primary_10_1007_s00221_021_06224_3
crossref_primary_10_1212_CPJ_0000000000000699
crossref_primary_10_3389_fneur_2022_1013652
crossref_primary_10_1080_02687038_2017_1381876
crossref_primary_10_1007_s00415_024_12344_x
crossref_primary_10_3233_ADR_220089
crossref_primary_10_1016_j_nicl_2022_102999
crossref_primary_10_1016_j_jcomdis_2020_106076
crossref_primary_10_1044_2019_AJSLP_18_0169
crossref_primary_10_1044_2021_JSLHR_21_00396
crossref_primary_10_1007_s00415_015_7821_5
crossref_primary_10_1044_2023_AJSLP_22_00296
crossref_primary_10_1212_WNL_0000000000200382
crossref_primary_10_1044_2023_JSLHR_23_00577
crossref_primary_10_1080_02687038_2020_1727709
crossref_primary_10_1111_1460_6984_12559
crossref_primary_10_1073_pnas_1614038114
crossref_primary_10_1590_2317_1782_20232022012pt
crossref_primary_10_1044_2024_AJSLP_23_00208
crossref_primary_10_1080_02643294_2021_2009790
crossref_primary_10_1080_02687038_2020_1765307
crossref_primary_10_1080_02687038_2019_1602813
crossref_primary_10_1017_S1355617721000692
crossref_primary_10_1044_2022_LSHSS_21_00164
crossref_primary_10_1080_13554794_2019_1646291
crossref_primary_10_3233_ADR220089
crossref_primary_10_1044_2020_JSLHR_20_00445
crossref_primary_10_1044_2018_JSLHR_L_18_0344
crossref_primary_10_1093_brain_awae016
crossref_primary_10_1044_2018_AJSLP_17_0227
crossref_primary_10_1212_WNL_0000000000007367
crossref_primary_10_1044_2020_JSLHR_20_00340
crossref_primary_10_1044_2018_AJSLP_18_0192
crossref_primary_10_1080_17549507_2022_2061593
crossref_primary_10_1016_j_neuroimage_2022_118938
crossref_primary_10_1212_WNL_0000000000209693
crossref_primary_10_1016_j_conctc_2021_100876
crossref_primary_10_1044_2020_AJSLP_20_00126
crossref_primary_10_1044_2024_JSLHR_23_00439
crossref_primary_10_1080_02687038_2018_1545992
crossref_primary_10_1080_2050571X_2017_1388488
crossref_primary_10_21849_cacd_2018_00304
crossref_primary_10_1007_s11910_023_01275_1
crossref_primary_10_1044_2024_AJSLP_23_00345
crossref_primary_10_1093_braincomms_fcae233
crossref_primary_10_1044_2019_AJSLP_19_00005
crossref_primary_10_1044_2019_AJSLP_19_00126
crossref_primary_10_1044_2020_AJSLP_19_00110
crossref_primary_10_1044_2020_AJSLP_19_00116
crossref_primary_10_1080_02687038_2024_2314323
crossref_primary_10_1007_s10072_019_04097_7
crossref_primary_10_1093_brain_awz157
crossref_primary_10_1186_s13063_021_05238_0
crossref_primary_10_1016_j_cortex_2017_12_021
crossref_primary_10_1080_17549507_2023_2263181
crossref_primary_10_1159_000524474
crossref_primary_10_14746_pspsj_2022_29_2_17
crossref_primary_10_1044_2022_AJSLP_22_00170
crossref_primary_10_1080_13554794_2021_1933541
crossref_primary_10_1044_2017_JSLHR_S_16_0443
crossref_primary_10_1007_s00415_020_10360_1
crossref_primary_10_1016_j_neuropsychologia_2019_02_018
crossref_primary_10_1016_j_nicl_2021_102934
crossref_primary_10_3389_fnins_2021_715928
crossref_primary_10_1016_j_clinph_2019_08_011
crossref_primary_10_1016_j_cortex_2020_08_013
crossref_primary_10_1016_j_nicl_2023_103394
crossref_primary_10_1080_02643294_2017_1394834
crossref_primary_10_1080_02687038_2016_1191054
crossref_primary_10_1044_2021_AJSLP_20_00402
crossref_primary_10_1016_j_cortex_2019_11_002
crossref_primary_10_1080_2050571X_2017_1379721
crossref_primary_10_1044_2022_JSLHR_22_00347
crossref_primary_10_1080_02699206_2020_1865460
crossref_primary_10_1080_02687038_2024_2441203
crossref_primary_10_61989_6kkkds06
crossref_primary_10_1044_2024_AJSLP_24_00104
crossref_primary_10_3233_ADR_230168
crossref_primary_10_1080_02699206_2022_2099302
crossref_primary_10_1044_2018_AJSLP_MSC18_18_0099
crossref_primary_10_1044_2024_PERSP_24_00002
crossref_primary_10_1016_j_parkreldis_2025_107272
crossref_primary_10_3233_JAD_201132
crossref_primary_10_1007_s10072_024_07758_4
crossref_primary_10_1002_mds_28901
crossref_primary_10_1016_j_cortex_2019_02_029
crossref_primary_10_1016_j_cortex_2023_08_019
crossref_primary_10_1016_j_cortex_2019_05_007
crossref_primary_10_1016_j_neurobiolaging_2022_08_013
crossref_primary_10_1080_09602011_2024_2362243
crossref_primary_10_1016_j_nrleng_2022_09_006
crossref_primary_10_1007_s00702_022_02550_0
crossref_primary_10_1161_STROKEAHA_115_010402
crossref_primary_10_1044_2023_AJSLP_22_00319
crossref_primary_10_1093_brain_awx293
crossref_primary_10_1044_2020_AJSLP_20_00135
crossref_primary_10_1016_j_nicl_2016_01_014
crossref_primary_10_1044_2020_AJSLP_20_00012
crossref_primary_10_1515_CJAL_2021_0035
crossref_primary_10_1044_2023_JSLHR_23_00242
crossref_primary_10_1044_2018_JSLHR_L_18_0048
crossref_primary_10_1016_j_jcomdis_2021_106090
crossref_primary_10_3233_JAD_230912
crossref_primary_10_3389_fneur_2021_694872
crossref_primary_10_1111_ene_15764
crossref_primary_10_1044_2019_AJSLP_CAC48_18_0227
crossref_primary_10_1044_2019_JSLHR_L_19_0213
crossref_primary_10_1111_nan_12535
crossref_primary_10_1016_j_bandl_2023_105254
crossref_primary_10_1044_2024_JSLHR_24_00049
crossref_primary_10_1044_2021_AJSLP_21_00058
crossref_primary_10_1044_2019_AJSLP_CAC48_18_0224
crossref_primary_10_1016_j_jns_2016_08_048
crossref_primary_10_1044_2019_AJSLP_CAC48_18_0225
Cites_doi 10.1080/02687030600597358
10.1093/brain/awl078
10.1044/1058-0360.0503.07
10.1093/brain/aws032
10.1097/WCO.0b013e3283168ddd
10.1044/1092-4388(2012/11-0318)
ContentType Journal Article
Copyright 2014 Elsevier Inc.
Elsevier Inc.
Copyright © 2014 Elsevier Inc. All rights reserved.
2014 Elsevier Inc. All rights reserved. 2014
Copyright_xml – notice: 2014 Elsevier Inc.
– notice: Elsevier Inc.
– notice: Copyright © 2014 Elsevier Inc. All rights reserved.
– notice: 2014 Elsevier Inc. All rights reserved. 2014
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1016/j.jcomdis.2014.06.008
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Psychology
EISSN 1873-7994
EndPage 50
ExternalDocumentID PMC4254321
25092638
10_1016_j_jcomdis_2014_06_008
S0021992414000598
1_s2_0_S0021992414000598
Genre Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIDCD NIH HHS
  grantid: R01 DC 10367
– fundername: NIDCD NIH HHS
  grantid: R01 DC000496
– fundername: NIDCD NIH HHS
  grantid: R01 DC010367
– fundername: NIDCD NIH HHS
  grantid: R01 DC 00496
GroupedDBID ---
--K
--M
--Z
-RU
-~X
.1-
.FO
.GJ
.~1
0R~
186
1B1
1P~
1RT
1~.
1~5
29K
3O-
4.4
457
4G.
53G
5GY
5RE
5VS
7-5
71M
85S
8P~
9JM
9JO
AADFP
AAEDT
AAEDW
AAFJI
AAGJA
AAGUQ
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AATTM
AAWTL
AAXKI
AAXLA
AAXUO
AAYJJ
AAYWO
ABBQC
ABCQJ
ABDPE
ABIVO
ABJNI
ABLJU
ABMAC
ABMMH
ABMZM
ABOYX
ABWJO
ABWVN
ABXDB
ACDAQ
ACGFS
ACHQT
ACIEU
ACJTP
ACRLP
ACRPL
ACVFH
ACXNI
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
AEBSH
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFJKZ
AFPUW
AFRHN
AFTJW
AFXBA
AFXIZ
AGCQF
AGHFR
AGQPQ
AGUBO
AGWIK
AGYEJ
AHHHB
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
AOMHK
APXCP
ASPBG
AVARZ
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CS3
D-I
DU5
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HMW
HMY
HVGLF
HZ~
IHE
J1W
KOM
KOO
M3V
M3Y
M41
MO0
MOBAO
N9A
NHB
O-L
O9-
OAUVE
OH0
OHT
OKEIE
OU-
OZT
P-8
P-9
P2P
PC.
PRBVW
Q38
R2-
ROL
RPZ
SDF
SDG
SDP
SES
SEW
SNG
SPCBC
SPS
SSB
SSH
SSN
SSO
SSS
SSY
SSZ
T5K
TN5
TWZ
UHS
WH7
WUQ
XJT
XOL
YQT
YYQ
Z5R
ZCG
ZGI
ZUP
ZXP
~G-
AACTN
AFCTW
AFKWA
AJOXV
AMFUW
RIG
YCJ
AADPK
AAIAV
ABLVK
ABYKQ
AFYLN
AGHSJ
AISVY
AJBFU
AKYCK
EFLBG
G8K
LCYCR
NAHTW
AAYXX
AGRNS
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ID FETCH-LOGICAL-c745t-4143b763d1a5f0b957997a53f3d63fc210d47ab06a587e65da89a71d4e8878b83
IEDL.DBID .~1
ISSN 0021-9924
1873-7994
IngestDate Thu Aug 21 18:27:15 EDT 2025
Fri Jul 11 03:20:04 EDT 2025
Tue Aug 05 09:37:46 EDT 2025
Thu Apr 03 07:02:44 EDT 2025
Tue Jul 01 03:24:04 EDT 2025
Thu Apr 24 23:00:48 EDT 2025
Fri Feb 23 02:25:22 EST 2024
Sun Feb 23 10:19:44 EST 2025
Tue Aug 26 16:32:01 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue NA
Keywords Differential diagnosis
Apraxia of speech
Subject description
Assessment
Language English
License Copyright © 2014 Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c745t-4143b763d1a5f0b957997a53f3d63fc210d47ab06a587e65da89a71d4e8878b83
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0001-8206-3432
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/4254321
PMID 25092638
PQID 1629966182
PQPubID 23479
PageCount 8
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_4254321
proquest_miscellaneous_1693606327
proquest_miscellaneous_1629966182
pubmed_primary_25092638
crossref_primary_10_1016_j_jcomdis_2014_06_008
crossref_citationtrail_10_1016_j_jcomdis_2014_06_008
elsevier_sciencedirect_doi_10_1016_j_jcomdis_2014_06_008
elsevier_clinicalkeyesjournals_1_s2_0_S0021992414000598
elsevier_clinicalkey_doi_10_1016_j_jcomdis_2014_06_008
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2014-09-01
PublicationDateYYYYMMDD 2014-09-01
PublicationDate_xml – month: 09
  year: 2014
  text: 2014-09-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Journal of communication disorders
PublicationTitleAlternate J Commun Disord
PublicationYear 2014
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Wertz, LaPointe, Rosenbek (bib0060) 1984
McNeil, Doyle, Wambaugh (bib0055) 2000
Duffy (bib0010) 2013
Kertesz (bib0045) 2007
Darley (bib0005) 1968
Josephs, Duffy, Strand, Whitwell, Layton, Parisi (bib0025) 2006; 129
Josephs, Duffy, Strand, Machulda, Senjem, Master (bib0030) 2012; 135
Kent (bib0040) 1996; 5
McNeil, Robin, Schmidt (bib0050) 2009
Duffy (bib0015) 2006; 20
Haley, Jacks, de Riesthal, Abou-Khalil, Roth (bib0020) 2012; 55
Josephs, Duffy (bib0035) 2008; 21
Duffy (10.1016/j.jcomdis.2014.06.008_bib0015) 2006; 20
Josephs (10.1016/j.jcomdis.2014.06.008_bib0030) 2012; 135
Kent (10.1016/j.jcomdis.2014.06.008_bib0040) 1996; 5
Kertesz (10.1016/j.jcomdis.2014.06.008_bib0045) 2007
Josephs (10.1016/j.jcomdis.2014.06.008_bib0035) 2008; 21
Haley (10.1016/j.jcomdis.2014.06.008_bib0020) 2012; 55
McNeil (10.1016/j.jcomdis.2014.06.008_bib0055) 2000
Josephs (10.1016/j.jcomdis.2014.06.008_bib0025) 2006; 129
McNeil (10.1016/j.jcomdis.2014.06.008_bib0050) 2009
Wertz (10.1016/j.jcomdis.2014.06.008_bib0060) 1984
Darley (10.1016/j.jcomdis.2014.06.008_bib0005) 1968
Duffy (10.1016/j.jcomdis.2014.06.008_bib0010) 2013
16613895 - Brain. 2006 Jun;129(Pt 6):1385-98
18989114 - Curr Opin Neurol. 2008 Dec;21(6):688-92
22382356 - Brain. 2012 May;135(Pt 5):1522-36
23033444 - J Speech Lang Hear Res. 2012 Oct;55(5):S1502-17
References_xml – year: 1968
  ident: bib0005
  article-title: Apraxia of speech: 107 Years of terminological confusion
  publication-title: Paper presented at the American speech and Hearing Association
– year: 2013
  ident: bib0010
  article-title: Motor speech disorders: Substrates, differential diagnosis, and management
– year: 2007
  ident: bib0045
  article-title: Western aphasia battery (revised)
– volume: 5
  start-page: 7
  year: 1996
  end-page: 23
  ident: bib0040
  article-title: Hearing and believing: Some limits to the auditory-perceptual assessment of speech and voice disorders
  publication-title: American Journal of Speech-Language Pathology
– volume: 55
  start-page: S1502
  year: 2012
  end-page: S1517
  ident: bib0020
  article-title: Toward a quantitative basis for assessment and diagnosis of apraxia of speech
  publication-title: Journal of Speech Language and Hearing Research
– year: 1984
  ident: bib0060
  article-title: Apraxia of speech in adults: The disorder and its management
– volume: 129
  start-page: 1385
  year: 2006
  end-page: 1398
  ident: bib0025
  article-title: Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech
  publication-title: Brain
– start-page: 221
  year: 2000
  end-page: 266
  ident: bib0055
  article-title: Apraxia of speech: A treatable disorder of motor planning and programming
  publication-title: Aphasia and language: Theory to practice
– volume: 20
  start-page: 511
  year: 2006
  end-page: 527
  ident: bib0015
  article-title: Apraxia of speech in degenerative neurologic disease
  publication-title: Aphasiology
– volume: 135
  start-page: 1522
  year: 2012
  end-page: 1536
  ident: bib0030
  article-title: Characterizing a neurodegenerative syndrome: Primary progressive apraxia of speech
  publication-title: Brain
– start-page: 249
  year: 2009
  end-page: 268
  ident: bib0050
  article-title: Apraxia of speech
  publication-title: Clinical management of sensorimotor speech disorders
– volume: 21
  start-page: 688
  year: 2008
  end-page: 692
  ident: bib0035
  article-title: Apraxia of speech and nonfluent aphasia: A new clinical marker for corticobasal degeneration and progressive supranuclear palsy
  publication-title: Current Opinion in Neurology
– start-page: 221
  year: 2000
  ident: 10.1016/j.jcomdis.2014.06.008_bib0055
  article-title: Apraxia of speech: A treatable disorder of motor planning and programming
– year: 1968
  ident: 10.1016/j.jcomdis.2014.06.008_bib0005
  article-title: Apraxia of speech: 107 Years of terminological confusion
– volume: 20
  start-page: 511
  year: 2006
  ident: 10.1016/j.jcomdis.2014.06.008_bib0015
  article-title: Apraxia of speech in degenerative neurologic disease
  publication-title: Aphasiology
  doi: 10.1080/02687030600597358
– volume: 129
  start-page: 1385
  year: 2006
  ident: 10.1016/j.jcomdis.2014.06.008_bib0025
  article-title: Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech
  publication-title: Brain
  doi: 10.1093/brain/awl078
– year: 2007
  ident: 10.1016/j.jcomdis.2014.06.008_bib0045
– year: 2013
  ident: 10.1016/j.jcomdis.2014.06.008_bib0010
– volume: 5
  start-page: 7
  year: 1996
  ident: 10.1016/j.jcomdis.2014.06.008_bib0040
  article-title: Hearing and believing: Some limits to the auditory-perceptual assessment of speech and voice disorders
  publication-title: American Journal of Speech-Language Pathology
  doi: 10.1044/1058-0360.0503.07
– year: 1984
  ident: 10.1016/j.jcomdis.2014.06.008_bib0060
– volume: 135
  start-page: 1522
  issue: May (Pt 5)
  year: 2012
  ident: 10.1016/j.jcomdis.2014.06.008_bib0030
  article-title: Characterizing a neurodegenerative syndrome: Primary progressive apraxia of speech
  publication-title: Brain
  doi: 10.1093/brain/aws032
– volume: 21
  start-page: 688
  year: 2008
  ident: 10.1016/j.jcomdis.2014.06.008_bib0035
  article-title: Apraxia of speech and nonfluent aphasia: A new clinical marker for corticobasal degeneration and progressive supranuclear palsy
  publication-title: Current Opinion in Neurology
  doi: 10.1097/WCO.0b013e3283168ddd
– volume: 55
  start-page: S1502
  year: 2012
  ident: 10.1016/j.jcomdis.2014.06.008_bib0020
  article-title: Toward a quantitative basis for assessment and diagnosis of apraxia of speech
  publication-title: Journal of Speech Language and Hearing Research
  doi: 10.1044/1092-4388(2012/11-0318)
– start-page: 249
  year: 2009
  ident: 10.1016/j.jcomdis.2014.06.008_bib0050
  article-title: Apraxia of speech
– reference: 18989114 - Curr Opin Neurol. 2008 Dec;21(6):688-92
– reference: 16613895 - Brain. 2006 Jun;129(Pt 6):1385-98
– reference: 22382356 - Brain. 2012 May;135(Pt 5):1522-36
– reference: 23033444 - J Speech Lang Hear Res. 2012 Oct;55(5):S1502-17
SSID ssj0016611
Score 2.4720256
Snippet •The ASRS quantifies the frequency/severity of the characteristics associated with AOS.•ASRS correlates with clinical diagnosis and severity of AOS.•Overall...
Highlights • The ASRS quantifies the frequency/severity of the characteristics associated with AOS. • ASRS correlates with clinical diagnosis and severity of...
The purpose of this report is to describe an initial version of the Apraxia of Speech Rating Scale (ASRS), a scale designed to quantify the presence or...
SourceID pubmedcentral
proquest
pubmed
crossref
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 43
SubjectTerms Adult
Aged
Aged, 80 and over
Aphasia - diagnosis
Apraxia of speech
Apraxias - diagnosis
Assessment
Diagnosis, Differential
Differential diagnosis
Humans
Middle Aged
Observer Variation
Psychiatry
Reproducibility of Results
Speech Production Measurement - methods
Subject description
Title The apraxia of speech rating scale: A tool for diagnosis and description of apraxia of speech
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0021992414000598
https://www.clinicalkey.es/playcontent/1-s2.0-S0021992414000598
https://dx.doi.org/10.1016/j.jcomdis.2014.06.008
https://www.ncbi.nlm.nih.gov/pubmed/25092638
https://www.proquest.com/docview/1629966182
https://www.proquest.com/docview/1693606327
https://pubmed.ncbi.nlm.nih.gov/PMC4254321
Volume 51
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF5VRUK9ICivtFAtEtc87N312tyiiCo8WiFEpV7Qah8T6qiyozqV6IXfzoxfEFJRxClKsmPHO7PfzGS_mWXstYh8im7NDVWgv24kLiknFQy9DkkasgBaUjXyyWkyP5Pvz9X5Dpt1tTBEq2yxv8H0Gq3bT8btbI5XeU41vjFxJyWmCFRCSQW_Umqy8tGPnuYRof9pTs0jKgKO_lXFM16OlnjxkFPX7kjWbTzplMnb_dN2_PknjfI3v3T8kD1oA0o-bX7zI7YDxT67f9Jume-zvR7ibh6zr2gV3K6u7Pfc8nLBqxWAv-BkBcU3XqG-4A2f8nVZXnKMZnloiHh5xW0ReIAeY0h46zpP2Nnx2y-z-bA9YAFVIdV6iFMnHAJMiKxaTBzt2GXaKrEQIRELj9lgkNq6SWJVqiFRwaaZ1VGQgNCUulQ8ZbtFWcBzxqVX3qEMJBIkTEIWCQDhnYdMuODSAZPdtBrfdh-nQzAuTUczW5pWG4a0YWq6HYqNerFV037jLoGk05npaksRDQ06iLsE9W2CULVrujKRqWIzMVt2N2BpL7lhuv9y01edWRlc1rRXYwsor_FmSUyZKGZ_fxuTCcw_RawH7Fljiv0kYWSbxYit-FgbRtoPoLbim98U-UXdXlxSf4Q4Ovj_xzpke_SuoeK9YLvrq2t4ibHb2h3Vi_OI3ZvOPn_8RK_vPsxPfwJINEbU
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKkaAXBOW1PI3EdR-J7cThVlVUC3R7aqVekGXHs21WVbJqthJc-ts7kziBZSuKuG48ycYz881MPA_GPooo12jW3FB5-nQjUaWcVDDMU59on3lIJVUjz46S6Yn8eqpOt9h-VwtDaZUB-1tMb9A6_DIOuzleFgXV-MaUOykxRKASSn2P3ZeovjTGYHTd53lEaIDasXmUi4DLf5XxjBejBd7dF9S2O5JNH08aM3m7gdp0QP_Mo_zNMB08Zo-CR8n32j_9hG1BucsezMKZ-S7b6THu51P2HcWC2-Wl_VFYXs15vQTIzzmJQXnGa2QYfOJ7fFVVFxzdWe7bTLyi5rb03EMPMkS8cZ9n7OTg8_H-dBgmLCAvpFoNce-EQ4TxkVXziaMjuyy1SsyFT8Q8x3DQy9S6SWKVTiFR3urMppGXgNiknRbP2XZZlfCScZmr3CENJBIkTHwWCQCRuxwy4bzTAya7bTV5aD9OUzAuTJdntjCBG4a4YZp8OyQb9WTLtv_GXQRJxzPTFZciHBq0EHcRprcRQh2UujaRqWMzMRuCN2C6p1yT3X956IdOrAzqNR3W2BKqK3xYElMoiuHf39ZkAgNQEacD9qIVxX6T0LXNYgRXfK01Ie0XUF_x9Stlcd70F5fUICGOXv3_a71nD6fHs0Nz-OXo22u2Q1favLw3bHt1eQVv0ZFbuXeNot4AH1RGzQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+apraxia+of+speech+rating+scale%3A+A+tool+for+diagnosis+and+description+of+apraxia+of+speech&rft.jtitle=Journal+of+communication+disorders&rft.au=Strand%2C+E+A&rft.au=Duffy%2C+J+R&rft.au=Clark%2C+H+M&rft.au=Josephs%2C+K&rft.date=2014-09-01&rft.issn=0021-9924&rft.volume=51&rft.issue=NA&rft_id=info:doi/10.1016%2Fj.jcomdis.2014.06.008&rft.externalDBID=NO_FULL_TEXT
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00219924%2FS0021992414X00067%2Fcov150h.gif